---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-039162"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2026-08-19T15:50:35+00:00"
generated_at: "2026-08-19T15:52:24.597624+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SRX Global Q3 net sales up 27% YoY; NAV $3.22/share beats estimate; declares dividend, buyback

## Summary
- Q3 net sales $3.4M, up 27% YoY; operating loss improved 63% to $3.2M; net loss from continuing ops $4.1M, improved 40% YoY
- NAV $62.9M or $3.22/share, above $3.07 preliminary estimate; $36.7M cash, $65.2M current assets, $2.4M liabilities, no debt
- Completed EMJX acquisition June 16, 2026; EMJX model max drawdown 10.6% vs 28-58% benchmarks; 4.3% gain in 14-day period vs Bitcoin -10.8%
- Declared one-time $0.05/share dividend (~$1.3M); approved 10M share repurchase program; 1-for-60 reverse split effective July 6, 2026
- Halo fill rates 93% avg, 98% in June; record Prime Day with 13% NTB growth, CPC $2.51 (8% below pet benchmark)

## SEC filing metadata
- accession: 0001493152-26-039162
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2026-08-19T15:50:35+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315226039162/0001493152-26-039162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315226039162/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-039162
- JSON: https://secwatch.observer/filing/0001493152-26-039162.json
- Plain text: https://secwatch.observer/filing/0001493152-26-039162.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.